AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 3449477
Drug: Definitive radiation
RxNorm normalized name: allantoin
DrugBank: Allantoin (DB11100)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Definitive radiation therapy (6,500‐7,000 rad)
Trial: 28696380
Drug: Whey protein
RxNorm normalized name: Whey protein
DrugBank: Whey (DB18685)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Whey protein (25 g of MuscleTech 100% Whey)
Trial: 28696380
Drug: Rested control
RxNorm normalized name: Crest
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Rested control trial (no exercise, no supplement)
Trial: 24611590
Drug: Lokomat therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lokomat therapy combined with conventional therapy (twice a week Lokomat + three times 30 min conventional therapy)
Trial: 24611590
Drug: Conventional assisted
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional assisted overground therapy only (3.5 h a week)
Trial: 8122957
Drug: Ketamine hydrochloride
RxNorm normalized name: Ketamine Hydrochloride
DrugBank: Ketamine (DB01221)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ketamine hydrochloride (0.1 mg/kg)
Trial: 2521863
Drug: CV 205-502
RxNorm normalized name: sodium bicarbonate
DrugBank: Sodium bicarbonate (DB01390)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: CV 205-502 (0.01-0.05 mg initially, increased to 0.03-0.09 mg at 12 weeks)
Trial: 9883
Drug: Hydrocortisone hemisucccinate
RxNorm normalized name: Hydrocortisone Hemisuccinate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydrocortisone hemisucccinate (150 mg/kg)
Trial: 9883
Drug: Methyl prednisolone
RxNorm normalized name: Prednisolone
DrugBank: Prednisolone acetate (DB15566)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Methyl prednisolone sulfate (30 mg/kg)
Trial: 9883
Drug: Prednisone sodium
RxNorm normalized name: Prednisone
DrugBank: Prednisone acetate (DB14646)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Prednisone sodium m sulfobenzoate (50 mg/kg)
Trial: 9883
Drug: Prednisolone sodium
RxNorm normalized name: Prednisolone Sodium Phosphate
DrugBank: Prednisolone acetate (DB15566)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Prednisolone sodium m sulfobenzoate (35 mg/kg)
Trial: 9883
Drug: Dexamethasone phosphate
RxNorm normalized name: Dexamethasone Phosphate
DrugBank: Dexamethasone acetate (DB14649)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Dexamethasone phosphate (2 mg and 6 mg/kg)
Trial: 25652389
Drug: Insulin deficiency
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Insulin deficiency (fasting C-peptide ≤0.15 nmol/l)
Trial: 25652389
Drug: Presence of
RxNorm normalized name: Dna Plasmid Expressing Diphtheria Toxin Triggered By The Presence Of Oncofetal Gene H19
DrugBank: Inodiftagene vixteplasmid (DB16017)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Presence of IAA autoantibodies or baseline insulin use
Trial: 15097308
Drug: 60 mg
RxNorm normalized name: opium 60 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 60 mg of elemental iron given twice weekly for four months
Trial: 15097308
Drug: Higher doses
RxNorm normalized name: BENZOCAINE 50 mg in 1 mL TOPICAL GEL [HIGHER CONTROL Male Climax Control Lubricating]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Higher doses of iron (not specified)
Trial: 10762511
Drug: Immunocytochemistry using
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immunocytochemistry using antibodies against phosphoepitopes
Trial: 8614771
Drug: Stress Management
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Stress Management Treatment (SMT)
Trial: 1466618
Drug: Recombinant human
RxNorm normalized name: Recombinant human TNF
DrugBank: Etanercept (DB00005)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Recombinant human growth hormone (GH) 0.1 mg/kg/day
Trial: 6704272
Drug: Conventional i.v.
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional i.v. morphine (control)
Trial: 24652598
Drug: Multi-professional treatment
RxNorm normalized name: Clearskin Professional Daily Correcting
DrugBank: Salicylic acid (DB00936)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multi-professional treatment within a clinical pathway
Trial: 23244640
Drug: Ecological momentary
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ecological momentary assessment (EMA) - self-monitoring negative thoughts five times daily for 2 weeks
Trial: 16434656
Drug: Vardenafil (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vardenafil (10 mg for 4 weeks, then maintained or titrated to 5 or 20 mg at weeks 4 and 8)
Trial: 11075309
Drug: Calcium citrate
RxNorm normalized name: Calcium Citrate
DrugBank: Calcium sulfate (DB15533)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Calcium citrate (Citracal 250 mg + D)
Trial: 11075309
Drug: Calcium carbonate
RxNorm normalized name: Calcium Carbonate
DrugBank: Calcium carbonate (DB06724)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Calcium carbonate (Os-Cal 500 mg + D)
Trial: 29867930
Drug: Multidrug therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multidrug therapy (MDT)
Trial: 21417535
Drug: Immediate cognitive-behavioral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immediate cognitive-behavioral therapy (CBT)
Trial: 21417535
Drug: Delayed cognitive-behavioral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Delayed cognitive-behavioral therapy (CBT)
Trial: 18332407
Drug: Chronic illness
RxNorm normalized name: Chromic Chloride
DrugBank: Chromic chloride (DB09129)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Chronic illness management initiative involving joint formulation of comprehensive individual patient care plans
Trial: 16520665
Drug: Sunitinib malate
RxNorm normalized name: Sunitinib Malate
DrugBank: Sunitinib (DB01268)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Sunitinib malate (SU11248) 50 mg after a high-fat, high-calorie meal
Trial: 16520665
Drug: Sunitinib malate
RxNorm normalized name: Sunitinib Malate
DrugBank: Sunitinib (DB01268)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Sunitinib malate (SU11248) 50 mg after a 10-h fast
Trial: 12920408
Drug: Other antipsychotics
RxNorm normalized name: Other antipsychotics
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Other antipsychotics and low doses of antiparkinsonians
Trial: 10914361
Drug: Rate adaptive
RxNorm normalized name: tacrolimus
DrugBank: Tacrolimus (DB00864)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Rate adaptive atrial pacing therapy
Trial: 10914361
Drug: No atrial
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No atrial pacing therapy
Trial: 1319601
Drug: Smoked marijuana
RxNorm normalized name: Picea mariana resin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Smoked marijuana and Oral THC
Trial: 6478738
Drug: Diazepam 20
RxNorm normalized name: diazePAM 20 mg rectal kit
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diazepam 20 mg + Methadone 100% of maintenance dose
Trial: 6478738
Drug: Diazepam 40
RxNorm normalized name: Diazepam 400 microgram/mL oral solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diazepam 40 mg + Methadone 150% of maintenance dose
Trial: 6478738
Drug: Methadone 100%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methadone 100% of maintenance dose
Trial: 6478738
Drug: Methadone 150%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methadone 150% of maintenance dose
Trial: 6478738
Drug: Methadone 200%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methadone 200% of maintenance dose
Trial: 30734266
Drug: mirikizumab 30
RxNorm normalized name: Mirikizumab
DrugBank: Mirikizumab (DB14910)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: mirikizumab 30 mg
Trial: 30734266
Drug: mirikizumab 100
RxNorm normalized name: mirikizumab 100 mg in 1 mL SUBCUTANEOUS INJECTION, SOLUTION [Omvoh]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: mirikizumab 100 mg
Trial: 30734266
Drug: mirikizumab 300
RxNorm normalized name: Mirikizumab
DrugBank: Mirikizumab (DB14910)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: mirikizumab 300 mg
Trial: 17869596
Drug: Levobupivacaine infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Levobupivacaine infusion (16.25mg/h for 24h)
Trial: 11448018
Drug: 66 mg/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 66 mg/day etidronate
Trial: 11448018
Drug: 133 mg/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 133 mg/day etidronate
Trial: 11448018
Drug: 200 mg/day
RxNorm normalized name: alpelisib 200 mg/day (200 mg x 1) ORAL TABLET
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg/day etidronate
Trial: 8040990
Drug: 99mTc MIBI
RxNorm normalized name: 99mTc medronate
DrugBank: Technetium Tc-99m medronate (DB09138)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 99mTc MIBI injection during stress testing
Trial: 17709433
Drug: Refined olive
RxNorm normalized name: Olive Oil
DrugBank: Olive oil (DB09567)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Refined olive oil (50 g/m² body surface area)
Trial: 17709433
Drug: High-palmitic sunflower
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-palmitic sunflower oil (50 g/m² body surface area)
Trial: 17709433
Drug: Butter (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Butter (50 g/m² body surface area)
Trial: 17709433
Drug: Mixture of
RxNorm normalized name: OCTADECANOL (MIXTURE OF ISOMERS)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mixture of vegetable and fish oils (50 g/m² body surface area)
Trial: 28375706
Drug: Diabetes without
RxNorm normalized name: Diabetic Tussin EX
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diabetes without metformin treatment
Trial: 28375706
Drug: Diabetes with
RxNorm normalized name: Diabetic Tussin EX
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diabetes with metformin treatment
Trial: 15153664
Drug: Fluvastatin 20
RxNorm normalized name: fluvastatin 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluvastatin 20 mg once daily for 12 weeks
Trial: 11286302
Drug: Oral trimetazidine
RxNorm normalized name: trimetazidine
DrugBank: Trimetazidine (DB09069)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral trimetazidine
Trial: 8900987
Drug: Inflated G-suit
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inflated G-suit (50 mm Hg)
Trial: 8900987
Drug: Non-inflated G-suit
RxNorm normalized name: Tavist Non-Sedating
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-inflated G-suit
Trial: 8900987
Drug: Without G-suit
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Without G-suit
Trial: 28650087
Drug: Oral health
RxNorm normalized name: CETYLPYRIDINIUM CHLORIDE 0.07 g in 100 mL ORAL RINSE [Assured Oral Health Fresh Mint]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral health educational strategy (OHES) and Atraumatic Restorative Treatment (ART) restoration
Trial: 28650087
Drug: Oral health
RxNorm normalized name: CETYLPYRIDINIUM CHLORIDE 0.07 g in 100 mL ORAL RINSE [Assured Oral Health Fresh Mint]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral health educational strategy (OHES)
Trial: 25866155
Drug: 5 g
RxNorm normalized name: 15 g/31 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 g of Lentinula edodes (shiitake) mushrooms daily
Trial: 25866155
Drug: 10 g
RxNorm normalized name: Co Q-10 Gummies
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 g of Lentinula edodes (shiitake) mushrooms daily
Trial: 24525232
Drug: Neoadjuvant chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neoadjuvant chemotherapy (methotrexate, vinblastine, doxorubicin, cisplatin)
Trial: 10394686
Drug: Dihydroergocristine 3
RxNorm normalized name: dihydroergocristine 3 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dihydroergocristine 3 mg + Piracetam 1.6 g every 12 hours for 90 days
Trial: 10394686
Drug: Dihydroergocristine 1.5
RxNorm normalized name: dihydroergocristine 1.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dihydroergocristine 1.5 mg + Piracetam 0.8 g every 8 hours for 90 days
Trial: 10394686
Drug: Dihydroergocristine 1.5
RxNorm normalized name: dihydroergocristine 1.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dihydroergocristine 1.5 mg + Piracetam 0.8 g every 8 hours
Trial: 8785138
Drug: Cis-atracurium 0.18
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cis-atracurium 0.18 mg kg‐1 h‐1 (group 1, n = 6)
Trial: 8785138
Drug: Atracurium 0.6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atracurium 0.6 mg kg‐1 h‐1 (group 2, n = 6)
Trial: 6149589
Drug: Smoked marijuana
RxNorm normalized name: Picea mariana resin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Smoked marijuana (1 g cigarette containing 1.83% delta 9-THC)
Trial: 6149589
Drug: Delta 9-THC
RxNorm normalized name: delta-9-THC
DrugBank: Dronabinol (DB00470)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Delta 9-THC (17.5 mg)
Trial: 6149589
Drug: Nabilone (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nabilone (2 mg orally)
Trial: 29530271
Drug: Levothyroxine (LT4)
RxNorm normalized name: LT4
DrugBank: Levothyroxine (DB00451)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Levothyroxine (LT4) treatment; specific dosage and duration not mentioned.
Trial: 11993621
Drug: CREATINE (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CREATINE (5 g of Cr, 4 times per day for 6 days)
Trial: 11993621
Drug: PLACEBO (same
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PLACEBO (same dosage of a glucose polymer)
Trial: 9513799
Drug: Morphine (16
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morphine (16 mg)
Trial: 2153355
Drug: Nedocromil sodium
RxNorm normalized name: Nedocromil Sodium
DrugBank: Nedocromil (DB00716)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nedocromil sodium (4 mg, 4 times daily for 4 months)
Trial: 2153355
Drug: Beclomethasone dipropionate
RxNorm normalized name: Beclomethasone Dipropionate
DrugBank: Beclomethasone dipropionate (DB00394)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beclomethasone dipropionate (100 micrograms, 4 times daily for 4 months)
Trial: 2153355
Drug: Placebo (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (4 times daily for 4 months)
Trial: 351886
Drug: Cadaver donor
RxNorm normalized name: Donor Human Stool
DrugBank: Fecal microbiota (DB17743)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cadaver donor pretreatment with 5 g of methylprednisolone and 7 g of cyclophosphamide
Trial: 25041383
Drug: Hydrogel patch
RxNorm normalized name: Hydrogen
DrugBank: Hydrogen (DB15127)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydrogel patch applied directly on the affected area three times within the first 24 hours, followed by three additional patches over the next 3 days.
Trial: 25041383
Drug: Hydrogel patch
RxNorm normalized name: Hydrogen
DrugBank: Hydrogen (DB15127)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydrogel patch
Trial: 21757278
Drug: Dextrose prolotherapy
RxNorm normalized name: Dextrose
DrugBank: Dextrose, unspecified form (DB09341)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dextrose prolotherapy (4 injections of 2 mL of 10% dextrose and 1 mL of 2% mepivacaine each 6 weeks apart)
Trial: 21757278
Drug: Placebo (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (4 injections of 2 mL of saline solution and 1 mL of 2% mepivacaine each 6 weeks apart)
Trial: 19840635
Drug: Intracanal medication
RxNorm normalized name: dexamethasone
DrugBank: Dexamethasone acetate (DB14649)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intracanal medication with 2% chlorhexidine gel (CHX)
Trial: 19840635
Drug: Canal preparation
RxNorm normalized name: Canal + Gel 10% for Root Canal Preparation Dental Gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Canal preparation with 1.3% NaOCl
Trial: 16759839
Drug: Meropenem 500
RxNorm normalized name: meropenem 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Meropenem 500 mg every 8h
Trial: 15373930
Drug: Monoclonal antibody
RxNorm normalized name: Monoclonal antibody
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Monoclonal antibody ATM-027
Trial: 9652559
Drug: Basiliximab (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Basiliximab (20 mg infusion on day 0 and day 4)
Trial: 3481627
Drug: Ofloxacin (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ofloxacin (1 and 4 mg/l)
Trial: 3481627
Drug: Loading dose
RxNorm normalized name: NUZYRA 7-Day Oral Pack including loading dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Loading dose of 400 mg ofloxacin with subsequent doses of 200 mg
Trial: 31758735
Drug: Sofosbuvir 200
RxNorm normalized name: sofosbuvir 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sofosbuvir 200 mg/ledipasvir 45 mg (8-week treatment)
Trial: 31758735
Drug: Sofosbuvir 200
RxNorm normalized name: sofosbuvir 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sofosbuvir 200 mg/ledipasvir 45 mg (12-week treatment)
Trial: 20207825
Drug: GH plus
RxNorm normalized name: Pediacare Cough Plus Cold
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GH plus raloxifene (R; 60 mg/d)
Trial: 20207825
Drug: GH plus
RxNorm normalized name: Pediacare Cough Plus Cold
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GH plus 17beta‐estradiol (E(2); 2 mg/d)
Trial: 20207825
Drug: GH therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GH therapy alone (0.5 mg/d)
Trial: 12685518
Drug: Other stimulant
RxNorm normalized name: Ether
DrugBank: Diethyl ether (DB13598)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Other stimulant medications
Trial: 12685518
Drug: Behavioral treatments
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Behavioral treatments
Trial: 7585848
Drug: Regimen A
RxNorm normalized name: CHLOROXYLENOL 5 g in 1000 mL TOPICAL SOAP [REGIMEN ANTIMICROBIAL]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Regimen A (contents from a 30‐mg capsule placed in a tablespoonful of applesauce)
Trial: 2106837
Drug: UFT (1‐(2‐tetrahydrofuryl)‐5‐fluorouracil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: UFT (1‐(2‐tetrahydrofuryl)‐5‐fluorouracil mixed with uracil) orally at a daily dose of 300 mg
Trial: 1164876
Drug: Dihydroergotamine treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dihydroergotamine treatment
Trial: 1164876
Drug: Dihydroergotamine treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dihydroergotamine treatment (low-risk patients)
Trial: 29178937
Drug: Levofloxacin 11
RxNorm normalized name: Levofloxacine
DrugBank: Levofloxacin (DB01137)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Levofloxacin 11 mg/kg/day
Trial: 29178937
Drug: Levofloxacin 14
RxNorm normalized name: Levofloxacine
DrugBank: Levofloxacin (DB01137)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Levofloxacin 14 mg/kg/day
Trial: 29178937
Drug: Levofloxacin 17
RxNorm normalized name: Levofloxacine
DrugBank: Levofloxacin (DB01137)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Levofloxacin 17 mg/kg/day
Trial: 29178937
Drug: Levofloxacin 20
RxNorm normalized name: levofloxacin
DrugBank: Levofloxacin (DB01137)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Levofloxacin 20 mg/kg/day
Trial: 29178937
Drug: Levofloxacin doses
RxNorm normalized name: Levofloxacin
DrugBank: Levofloxacin (DB01137)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Levofloxacin doses (11, 14, 17, 20 mg/kg/day)
Trial: 23948958
Drug: Low-dose/no statins
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-dose/no statins
Trial: 21930596
Drug: IH with
RxNorm normalized name: trenbolone acetate 80 mg / estradiol 8 mg / tylosin tartrate 29 mg SUBCUTANEOUS IMPLANT [Component TE-IH With Tylan]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IH with losartan (AT(1) receptor antagonist)
Trial: 20061584
Drug: Gemfibrozil (60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gemfibrozil (60 mg/kg/dose)
Trial: 12160759
Drug: Iridium-192 intracoronary
RxNorm normalized name: iridium
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iridium-192 intracoronary radiation therapy (IRT)
Trial: 7955971
Drug: Twice daily
RxNorm normalized name: CAPSULE, TWICE DAILY
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Twice daily isophane (Protaphane)
Trial: 7955971
Drug: Three times
RxNorm normalized name: WELLBUTRIN 100 MG Oral Tablet, Three Times Daily
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Three times daily soluble insulin (Actrapid)
Trial: 7955971
Drug: Protaphane therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Protaphane therapy
Trial: 7955971
Drug: Actrapid therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Actrapid therapy
Trial: 7955971
Drug: Insulin therapy
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Insulin therapy (both regimens)
Trial: 3297124
Drug: Indomethacin (375
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indomethacin (375 mg over 3 days)
Trial: 3297124
Drug: Propranolol (circa
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol (circa 40 mg i.v. over 60 min)
Trial: 3297124
Drug: VIP infusion
RxNorm normalized name: VIP
DrugBank: Vasoactive intestinal peptide (DB18634)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: VIP infusion (6 pmol kg-1 min-1)
Trial: 16680933
Drug: Diphenhydramine 50
RxNorm normalized name: diphenhydrAMINE 50 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diphenhydramine 50 mg, 3 times daily
Trial: 16680933
Drug: Desloratadine 5
RxNorm normalized name: desloratadine 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Desloratadine 5 mg, once daily
Trial: 9002102
Drug: C-aPDT vaccine
RxNorm normalized name: Meningococcal polysaccharide vaccine group C
DrugBank: Meningococcal polysaccharide vaccine group C (DB13890)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: C-aPDT vaccine (Chiron/Biocine)
Trial: 9002102
Drug: wDPT vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: wDPT vaccine (Connaught)
Trial: 9002102
Drug: Lederle aPDT
RxNorm normalized name: Lederfen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lederle aPDT vaccine